CLINICAL_TRIALS
trial_result
· 2023-05-22
Clinical Trial Update: A Phase # Clinical Study Trial of Felbinac Trometamol Injection in China [Phase 3]
Summary
Phase 3 clinical trial of Felbinac Trometamol Injection for pain in China has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shijiazhuang Yiling Pharmaceutical Co. Ltd | Conditions: Pain | Phase 3 | Status: COMPLETED